Articles

Bribery scandals sap Lilly’s China growth

Eli Lilly and Co. has been counting on torrid growth in China to help offset losses from patent expirations in other markets, but now slower growth in the Chinese economy and bribery allegations against Lilly and two other drugmakers have hampered Lilly’s growth there.

Read More

Health law fuels modest rise in costs

It’s long been known that Obamacare would make health benefits more expensive for most employers. Now, it’s finally becoming clearer by how much: about 9 percent, on average, according to a series of actuarial studies.

Read More

Builders of Obama’s health website saw red flags

The government spent at least $394 million in contracts to build the federal health care exchange and data hub. The painfully slow and often unresponsive website has frustrated Americans trying to enroll for insurance plans.

Read More

Indiana’s insurance exchanges are pricey

The premiums offered by health insurers participating in the Obamacare exchanges put Indiana among the 10 most-expensive states in the country, according to data released last month by the U.S. Department of Health and Human Services.

Read More